| Literature DB >> 26082884 |
William H Gmeiner1, Supratim Ghosh1.
Abstract
Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great specificity through both active and passive targeting. In this review, we summarize recent literature that has broken new ground in the use of nanotechnology for cancer treatment with an emphasis on targeted drug delivery.Entities:
Keywords: cancer; drug-delivery; nanotechnology
Year: 2015 PMID: 26082884 PMCID: PMC4465796 DOI: 10.1515/ntrev-2013-0013
Source DB: PubMed Journal: Nanotechnol Rev ISSN: 2191-9089 Impact factor: 7.848